Compositions useful as inhibitors of JAK and other protein kinases
US7312227B2 · kind B2 · utility
53Cited by
1References
50Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 3, 2003 |
| Grant date | Dec 25, 2007 |
| Priority date | — |
| Expiry date | Aug 14, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D409/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a compound of formula I:or a pharmaceutically acceptable salt thereof. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of utilizing those compounds and compositions in the treatment of various protein kinase mediated disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.